The breast cancer has been one of the most dangerous cancers threatening the health and wellbeing of human beings. Only in the UK more than 55000 cases are reported per year, with a significant increasing trend. The early detection of breast cancer has been proven as a key approach to improve the chances of survival for patients, which will also reduce the economic burden and physical suffering during the treatment procedure.

Different technologies have been developed to the detection of stage 0 breast cancer, that is DCIS (Ductal Carcinoma in Situ). While severe limitations exist among most of them, which makes them difficult to be widely employed as an efficient detection methods. Therefore, the MAMMOBOT has been proposed and developed to address these limitations, which is a robotic platform based on millimetre-scale steerable soft growing robot for surgical applications. It aims to access the breast through the nipple and navigate the mammary ducts to detect the precursors of earlystage breast cancers.